SelectDr Raises $2.04M Seed Round to Expand Data-Driven Doctor Recommendation Platform
SelectDr, an Atlanta‑based healthtech startup focused on helping patients find the right in‑network doctors through objective, data‑driven recommendations, has raised $2.04 million in seed funding as it looks to scale its healthcare navigation platform and expand partnerships with payers and enterprise clients. The raise marks a key early financing milestone for the company, which launched in 2024 with the goal of reducing inefficiencies in provider selection and improving health outcomes by giving patients evidence‑based insights into physician expertise and clinical results.
Founded by Rob Draughon and a team of healthcare and technology veterans, SelectDr was built around the idea that choosing the right doctor — based on objective clinical data rather than subjective reviews or word‑of‑mouth recommendations — can materially affect treatment success, reduce unnecessary procedures and generate significant cost savings across health systems and employer health plans. The company’s platform integrates data on physician outcomes, procedure volume, complication rates and other clinical measures to provide tailored recommendations for individual patients’ health needs.
The seed round was led by TechSquare Ventures, a venture capital firm based in Atlanta known for backing early‑ and growth‑stage technology companies across sectors including healthcare, software and digital infrastructure. TechSquare’s lead investment signals confidence in SelectDr’s potential to transform how people navigate care decisions and access high‑quality medical providers.
While the full list of participating investors has not been publicly disclosed, the involvement of TechSquare Ventures — a firm with a track record of supporting startups that blend data analytics and real‑world impact — suggests that SelectDr’s mission resonates with backers focused on outcomes‑oriented healthcare innovation. This seed capital will provide the company with the runway to accelerate product development, grow its data science and engineering teams and deepen strategic partnerships with employers, payers and health systems.
SelectDr aims to address a persistent challenge in the U.S. healthcare system: vast variability in clinical quality and patient outcomes across providers. Traditional methods of choosing a doctor — based on online reviews, referrals from friends and family, or simple search results — often overlook key clinical performance indicators that define true expertise for specific conditions or procedures. By making objective performance data accessible and actionable, SelectDr seeks to reduce unnecessary costs, avoid overtreatment and improve the quality of patient journeys.
According to industry observers, the startup’s focus on delivering measurable value to employers and health plans could be a compelling selling point as healthcare costs rise and organizations look for ways to optimize benefits spending. SelectDr’s platform is offered as an employee benefit, giving companies a tool to help their workforce make more informed care decisions while potentially lowering aggregate healthcare expenditures.
In addition to enhancing its core recommendation engine, the seed funding is expected to support SelectDr’s efforts in expanding its dataset and refining algorithms that match patients to clinicians with proven expertise for their specific health concerns. This work involves aggregating clinical outcome data from diverse sources, standardizing quality metrics and ensuring that the platform’s recommendations are transparent and easy for users to understand.
SelectDr’s founders have also emphasized their intention to build strong payer relationships, positioning the company as a partner to health insurers and self‑insured employers who stand to benefit from reduced waste and improved care quality. These partnerships could help integrate SelectDr’s insights into broader care management and utilization strategies, aligning incentives among patients, providers and payers.
As the company advances its product and goes to market, it will be competing in a growing segment of healthcare technology focused on decision support, care navigation and data‑driven provider transparency. SelectDr’s early funding and investor backing provide it with a platform to differentiate through clinical rigor and a user‑centric experience designed to simplify complex healthcare choices.
Looking ahead, SelectDr is positioned to use its seed funding to build momentum in the healthcare market, leveraging objective data and analytics to empower better care decisions. With its technology and strategic vision supported by early investor confidence, the company aims to play a role in shaping a more efficient, transparent and outcome‑focused healthcare system.
